A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204)
Galler, A.S.; Bauer, T.L.
Yearbook of Oncology 2009: 194-195
2009
DOI: 10.1016/s1040-1741(09)79280-2Document Number: 389639
Document emailed within 0-6 h
Related Documents
Liu, S.-j.; Di, L.-j.; Wang, J.; Li, R.; Yang, L.; Sun, H.; Zhang, M.-h.; Li, L.; Liu, J.-w.; Gao, Y.-j.; Sun, H.; Xu, G.-w. 2003: Phase Ii clinical trial on gemcitabine in the treatment of stage IIIB-IV non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 25(6): 584-586Rusch, V.W.; Albain, K.S.; Crowley, J.J.; Rice, T.W.; Lonchyna, V.; McKenna, R.; Livingston, R.B.; Griffin, B.R.; Benfield, J.R. 1993: Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial Journal of Thoracic and Cardiovascular Surgery 105(1): 97
Natale, R.B. 1996: Preliminary results of a phase I/Ii clinical trial of paclitaxel and carboplatin in non-small cell lung cancer Seminars in Oncology 23(6 Suppl 16: 51-54
Jones, A.L.; Holborn, J.; Ashley, S.; Smith, I.E. 1991: Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide European Journal of Cancer 27(7): 866-870
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
1997: Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. The Swiss Group for Clinical Cancer Research (SAKK) European Journal of Surgery 163(9): 693-701
Syrigos, K.N.; Konstantinou, M.; Sepsas, E.; Papamichales, G.; Loullias, A.; Belenis, I.; Skottis, I.; Charpidou, A.; Roussos, C. 2007: Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study Anticancer Research 27(4c): 2887-2892
Cigolari, S.; Curcio, C.; Maiorino, A.; Sessa, R.; Cioffi, A.; Massimo, M. 2003: Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study Anticancer Research 23(2c): 1803-1809
Boven, E.; Tierie, A.H.; Stam, J.; Pinedo, H.M. 1988: Combined radiation therapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer: results of a phase Ii trial Seminars in Oncology 15(6 Suppl 7: 18-19
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Nakazato, H.; Ichihashi, H.; Kondo, T. 1986: Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(2): 308-318
Garin, A.M.; Gorbunova, V.A.; Bychkov, M.B.; Mindra, N.V.; Stenina, M.B.; Topchieva, S.V.; Treshchalina, E.M.; Chitiia, L.V.; Sdvizhkov, A.M.; Borisov, V.I.; Gurov, S.N.; Gershanovich, M.L.; Makhnova, E.V.; Nebol'sin, V.E. 2004: Results of a multicenter, phase-Ii clinical trial of Dicarbamin used to shield leukopoiesis in cancer patients with immunosuppression due to chemotherapy Voprosy Onkologii 50(2): 184-188
Williams, C.J.; Woods, R.; Levi, J.; Page, J. 1988: Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy Seminars in Oncology 15(6 Suppl 7: 58-61
Vogt, H.G.; Kolotas, C.; Martin, T.; Schneider, L.V.; Goes-Schmieder, R.; Mitrou, P.S.; Diergarten, K.; Kober, B.; Zamboglou, N. 1996: Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase i study Seminars in Oncology 23(6 Suppl 16: 120-123
Uchikov, A.; Murdzhev, K.; Batashki, I.; Prisadov, G.; Uchikova, E. 2007: Remote results in operated patients with non-small cell lung cancer in IIi clinical stage Khirurgiia 5: 41-42
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Luckett, T.; Phillips, J.; Agar, M.; Lam, L.; Davidson, P.M.; McCaffrey, N.; Boyle, F.; Shaw, T.; Currow, D.C.; Read, A.; Hosie, A.; Lovell, M. 2018: Protocol for a phase III pragmatic stepped wedge cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of screening and guidelines with, versus without, implementation strategies for improving pain in adults with cancer attending outpatient oncology and palliative care services: the Stop Cancer PAIN trial Bmc Health Services Research 18(1): 558
Gatzemeier, U.; Manegold, C.; Eberhard, W.; Wilke, H.J.; Chomy, F.; Chomy, P.; Khayat, D.; Blatter, J.; Seeber, S.; Drings, P. 1998: Ifosfamide and gemcitabine: a phase Ii trial in advanced inoperable non-small cell lung cancer Seminars in Oncology 25(1 Suppl 2: 15-18
Yoshimura, A.; Yamano, Y.; Gemma, A.; Yoshimori, K.; Hayashihara, K.; Taniguchi, Y.; Uematsu, K.; Shibuya, M.; Kudoh, S.; Niitani, H. 1993: An early phase Ii trial combining cisplatin and carboplatin in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(4): 503-508